Screener
Stoke Therapeutics, Inc. STOK Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
FAQ
- What is Stoke Therapeutics, Inc.'s net debt?
- Stoke Therapeutics, Inc. (STOK) reported net debt of -$152.24M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s net debt changed year-over-year?
- Stoke Therapeutics, Inc.'s net debt increased by 43.4% year-over-year, from -$268.87M to -$152.24M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s net debt has grown at a -22.5% compound annual growth rate (CAGR), from -$286.16M to -$80.07M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Stoke Therapeutics, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude